Arkolith/Insider Trading/ATHA/Form 4

Perceptive Advisors LLC

Director, 10% OwnerAthira Pharma, Inc. (ATHA) · full profile →Form 4 · filed Dec 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
2 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)989K$6.35$6.3M1.5M
Dec 23, 2025Grant(A)330K$6.35$2.1M330K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)5.5M——5.5M
Dec 23, 2025Grant(A)1.2M$6.35$7.5M1.2M
Dec 23, 2025Grant(A)458K$6.35$2.9M458K
Dec 23, 2025Grant(A)3.5M$6.35$22.5M3.5M
Dec 23, 2025Grant(A)3.8M$6.35$24.4M3.8M
Dec 23, 2025Grant(A)1.4M$6.35$8.7M1.4M
Dec 23, 2025Grant(A)1.3M$6.35$8.1M1.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-25-000979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Athira Pharma, Inc.

Build

Ask your agent about ATHA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001012975-25-000979"
Ask your agent
Use Arkolith to summarize insider buying and selling at Athira Pharma, Inc.
over the last 90 days and cite the filings.